About Serine/threonine-protein kinase Sgk1
Serine/threonine-protein kinase Sgk1 (SGK1) is a protein
from Homo sapiens identified by UniProt accession
O00141, 431 residues long.
MolForge cross-references it against 0 known binders and
478 disease associations.
Target properties
| Protein name | Serine/threonine-protein kinase Sgk1 |
| UniProt accession | O00141 |
| Gene | SGK1 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (478)
Diseases linked to this target (Open Targets).
- electrocardiography · score 0.49
- diffuse large B-cell lymphoma · score 0.49
- calcium measurement · score 0.48
- hair color · score 0.45
- neurodegenerative disease · score 0.37
- hair colour measurement · score 0.34
- blood phosphate measurement · score 0.34
- venous thromboembolism · score 0.33
- protein measurement · score 0.33
- mean corpuscular hemoglobin · score 0.31
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00141-F1 | alphafold | PREDICTED | 79.75 | — |
Amino-acid sequence (431 residues)
MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE EVFYAVKVLQ KKAILKKKEE KHIMSERNVL LKNVKHPFLV GLHFSFQTAD KLYFVLDYIN GGELFYHLQR ERCFLEPRAR FYAAEIASAL GYLHSLNIVY RDLKPENILL DSQGHIVLTD FGLCKENIEH NSTTSTFCGT PEYLAPEVLH KQPYDRTVDW WCLGAVLYEM LYGLPPFYSR NTAEMYDNIL NKPLQLKPNI TNSARHLLEG LLQKDRTKRL GAKDDFMEIK SHVFFSLINW DDLINKKITP PFNPNVSGPN DLRHFDPEFT EEPVPNSIGK SPDSVLVTAS VKEAAEAFLG FSYAPPTDSF L
Explore Serine/threonine-protein kinase Sgk1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets